Home > Insider Trading > Filing (0001181431-12-041512)

Filing Details

Accession Number:: 0001181431-12-041512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-20 14:42:51
Reporting Period:: 2012-07-18

Filing Date:: 2012-07-20
Accepted Time:: 2012-07-20 14:42:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242215	C Joseph Papa	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010	President And Ceo	Yes	Yes	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-07-18	8,437	$20.50	108,437	No	4	M	Direct
Common Stock	Disposition	2012-07-18	1,500	$114.06	106,937	No	4	S	Direct
Common Stock	Disposition	2012-07-18	6,937	$115.13	100,000	No	4	S	Direct
Common Stock	Acquisiton	2012-07-18	1,563	$35.85	101,563	No	4	M	Direct
Common Stock	Disposition	2012-07-18	300	$114.14	101,263	No	4	S	Direct
Common Stock	Disposition	2012-07-18	1,263	$115.16	100,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option Right to Buy	Disposition	2012-07-18	8,437	$0.00	8,437	$20.50
Common Stock	Employee Stock Option Right to Buy	Disposition	2012-07-18	1,563	$0.00	20,176	$35.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-08-30	2017-08-30	No	4	M	Direct
18,613	2009-08-25	2018-08-25	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 29, 2011. This 10b5-1 sales plan will expire on the close of business November 20, 2012.
The price in column 4 is a weighted average. The prices actually received ranged from $113.67 to $114.60. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $114.79 to $115.49. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $113.88 to $114.36. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $114.98 to $115.49. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.